Compliance, litigation, and regulatory enforcement are unpopular topics that elicit a coordinated groan from buyers and sellers alike in healthcare M&A. These issues add unwanted hair to a deal that may otherwise generate significant returns. In the healthcare market, these risks are all too real. Department of Justice (DOJ) healthcare
enforcement has increased by 50%, with settlement amounts increasing by 172% over the past five years.
While the winds aren’t changing anytime soon, there is a brighter side: middle-market healthcare M&A has seen a dramatic increase in deal flow despite
these additional risks.
This article, authored by Chris Haney, Director in Duff & Phelps’ Dispute Consulting practice, will highlight the best practices to mitigate the risks of enforcement, close the deal, and reduce overall litigation costs in Healthcare M&A.
Click here to read the full article.
